Genetic contributors to sporadic AD (so-called “risk-genes”) have also informed understanding about mechanisms of brain resilience and vulnerability to AD with variants like APOE2 (apolipoprotein E epsilon 2) reducing risk while APOE4 is associated with a large increase in risk of developing AD. This evidence concerns the gene APOE and Alzheimer disease.